Noteworthy findings included genes associated with aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects and Estrogen‐dependent nuclear events downstream of ESR‐membrane signaling, hinting at intricate molecular mechanisms contributing to the therapeutic effects, as highlighted in Figure 2E. This evidence concerns the gene RB1 and cancer.